Elevated levels of serum MiR-152 and miR-24 in uterine sarcoma: potential for inducing autophagy via SIRT1 and deacetylated LC3

References

• Reichardt P. The treatment of uterine sarcomas. Ann Oncol. 2012;23:151–157.10.1093/annonc/mds359
   Web of Science ®Google Scholar
• Reed NS, Mangioni C, Malmstrom H, et al. Phase III randomised study to evaluate the role of adjuvant pelvic radiotherapy in the treatment of uterine sarcomas stages I and II: An European Organisation for Research and Treatment of Cancer Gynaecological Cancer Group Study (protocol 55874). Eur J Cancer. 2008;44:808–818.10.1016/j.ejca.2008.01.019
   PubMed Web of Science ®Google Scholar
• Abeler VM, Røyne O, Thoresen S, et al. Uterine sarcomas in Norway. A histopathological and prognostic survey of a total population from 1970 to 2000 including 419 patients. Histopathology. 2009;54:355–364.10.1111/his.2009.54.issue-3
   PubMed Web of Science ®Google Scholar
• Prat J. FIGO staging for uterine sarcomas. Int J Gynaecol Obstet. 2009;104:177–178.10.1016/j.ijgo.2008.12.008
   PubMed Web of Science ®Google Scholar
• Major FJ, Blessing JA, Silverberg SG, et al. Prognostic factors in early-stage uterine sarcoma. A Gynecol Oncol Group Study Cancer. 1993;71:1702–1709.
   Google Scholar
• Medina-Berlanga R, Blancas S, Santos L. Biomarker assessment in cervical uterine cancer: IGCS-0055 Cervical Cancer. Int J Gynecol Cancer. 2015;25:20.10.1097/00009577-201505001-00016
   PubMed Web of Science ®Google Scholar
• Cocco E, Bellone S, El-Sahwi K, et al. Serum amyloid A (SAA): a novel biomarker for uterine serous papillary cancer. Br J Cancer. 2009;101:335–341.10.1038/sj.bjc.6605129
   PubMed Web of Science ®Google Scholar
• Sun B, Liu X, Gao Y, et al. Downregulation of miR-124 predicts poor prognosis in pancreatic ductal adenocarcinoma patients. Br J Biomed Sci. 2016;73:152–157.10.1080/09674845.2016.1220706
   PubMed Web of Science ®Google Scholar
• Ren X, Shen Y, Zheng S, et al. miR-21 predicts poor prognosis in patients with osteosarcoma. Br J Biomed Sci. 2016;73:158–162.10.1080/09674845.2016.1220710
   PubMed Web of Science ®Google Scholar
• Yadegari ZS, Akrami H, Hosseini SV, et al. miR-146a gene polymorphism and susceptibility to gastric cancer. Br J Biomed Sci. 2016;73:201–203.10.1080/09674845.2016.1233790
   PubMed Web of Science ®Google Scholar
• Liu C, Xing M, Wang L, et al. miR-199a-3p downregulation in thyroid tissues is associated with invasion and metastasis of papillary thyroid carcinoma. Br J Biomed Sci. 2017;74:90–94.
   PubMed Web of Science ®Google Scholar
• Yu FS, Yu CS, Chen JC, et al. Tetrandrine induces apoptosis via caspase-8, -9, and-3 and poly (ADP ribose) polymerase dependent pathways and autophagy through beclin-1/LC3-I, II signaling pathways in human oral cancer HSC-3 cells. Environ Toxicol. 2016;31:395–406.10.1002/tox.v31.4
   PubMed Web of Science ®Google Scholar
• Castro L, Gao X, Moore AB, et al. A high concentration of genistein induces cell death in human uterine leiomyoma cells by autophagy. Expert Opin Environ Biol. 2016;5:1–19.
   Google Scholar
• Li X, Wang YJ, Xiong YZ, et al. Galangin induces autophagy via deacetylation of LC3 by SIRT1 in HepG2 cells. Sci Rep. 2016;6:30496.10.1038/srep30496
   PubMed Web of Science ®Google Scholar
• Martin AJ, Alfonso PG, Ruperez AB, et al. Nab-paclitaxel plus gemcitabine as first-line palliative chemotherapy in a patient with metastatic pancreatic cancer with Eastern Cooperative Oncology Group performance status of 2. Oncol Lett. 2016;12:727–730.
   PubMed Web of Science ®Google Scholar
• Li J, Cai Y, Ke G, et al. Validation of the new FIGO staging system (2009) for vulvar cancer in the Chinese population. Gynecol Oncol. 2015;137:274–279.10.1016/j.ygyno.2015.03.001
   PubMed Web of Science ®Google Scholar
• Li B, Xie Z, Li B. miR-152 functions as a tumor suppressor in colorectal cancer by targeting PIK3R3. Tumour Biol. 2016;37:10075–10084.10.1007/s13277-016-4888-2
   PubMedGoogle Scholar
• Zhang YJ, Liu XC, Du J, et al. MiR-152 regulates metastases of non-small cell lung cancer cells by targeting neuropilin-1. Int J Clin Exp Pathol. 2015;8:14235–14240.
   PubMed Web of Science ®Google Scholar
• Torres A, Kozak J, Korolczuk A, et al. Locked nucleic acid-inhibitor of miR-205 decreases endometrial cancer cells proliferation in vitro and in vivo. Oncotarget. 2016;7:73651–73663.
   PubMed Web of Science ®Google Scholar
• Eyking A, Reis H, Frank M, et al. MiR-205 and MiR-373 are associated with aggressive human mucinous colorectal cancer. Plos One. 2016;11:e0156871.10.1371/journal.pone.0156871
   PubMed Web of Science ®Google Scholar
• Wang DD, Yang SJ, Chen X, et al. miR-222 induces Adriamycin resistance in breast cancer through PTEN/Akt/p27kip1 pathway. Tumour Biol. 2016;37:15315–15324.10.1007/s13277-016-5341-2
   PubMedGoogle Scholar
• Lynch SM, McKenna MM, Walsh CP, et al. miR-24 regulates CDKN1B/p27 expression in prostate cancer. Prostate. 2016;76:637–648.10.1002/pros.v76.7
   PubMed Web of Science ®Google Scholar
• Dinh TK, Fendler W, Chalubinska-Fendler J, et al. Circulating miR-29a and miR-150 correlate with delivered dose during thoracic radiation therapy for non-small cell lung cancer. Radiat Oncol. 2016;11:61.10.1186/s13014-016-0636-4
   PubMed Web of Science ®Google Scholar
• Kelly KL, Craighead PS. Characteristics and management of uterine sarcoma patients treated at the Tom Baker Cancer Centre. Int J Gynecol Cancer. 2005;15:132–139.10.1111/ijg.2005.15.issue-1
   PubMed Web of Science ®Google Scholar
• D’Angelo E, Prat J. Uterine sarcomas: a review. Gynecol Oncol. 2010;116:131–139.10.1016/j.ygyno.2009.09.023
   PubMed Web of Science ®Google Scholar
• Benito V, Lubrano A, Arencibia O, et al. Clinicopathologic analysis of uterine sarcomas from a single institution in the Canary Islands. Int J Gynaecol Obstet. 2009;107:44–49.10.1016/j.ijgo.2009.05.020
   PubMed Web of Science ®Google Scholar
• Ghaemmaghami F, Karimi-Zarchi M, Gilani MM, et al. Uterine sarcoma: clinicopathological characteristics, treatment and outcome in Iran. Asian Pac J Cancer Prev. 2008;9:421–426.
   PubMedGoogle Scholar
• Sartori E, Bazzurini L, Gadducci A, et al. Carcinosarcoma of the uterus: a clinicopathological multicenter CTF study. Gynecol Oncol. 1997;67:70–75.10.1006/gyno.1997.4827
   PubMed Web of Science ®Google Scholar
• Tsikouras P, Liberis V, Galazios G, et al. Uterine sarcoma: a report of 57 cases over a 16-year period analysis. Eur J Gynaecol Oncol. 2008;29:129–134.
   PubMed Web of Science ®Google Scholar
• Jiang K, Liu M, Lin G, et al. Tumor suppressor Spred2 interaction with LC3 promotes autophagosome maturation and induces autophagy-dependent cell death. Oncotarget. 2016;7:25652–25667.
   PubMed Web of Science ®Google Scholar